Related Experiment Video
Updated: Feb 2, 2026

Isolation and Characterization of Microvesicles from Peripheral Blood
Published on: January 6, 2017
BLTR1 and CD36 Expressing Microvesicles in Atherosclerotic Patients and Healthy Individuals
Mathilde Sanden1, Jaco Botha1,2, Michael René Skjelbo Nielsen3
1Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.
Insights
This study explores monocyte-derived microvesicles (MMVs) in atherosclerosis, finding lower BLTR1+ MMVs in patients. CD14+ MMVs inversely correlate with arachidonic acid, suggesting potential as atherosclerosis biomarkers.
Area of Science:
- Cardiovascular Biology
- Immunology
- Lipid Metabolism
Background:
- Monocytes/macrophages are key in atherosclerosis development and complications.
- CD36-mediated oxLDL uptake drives foam cell formation and monocyte activation, releasing monocyte-derived microvesicles (MMVs).
- Leukotriene B4 (LTB4), derived from arachidonic acid, exacerbates atherosclerosis via the BLTR1 receptor.
Purpose of the Study:
- To investigate the correlation between distinct MMV phenotypes (CD14+ MVs) and the levels of arachidonic acid and eicosapentaenoic acid.
- To analyze these correlations across various biological compartments, including atherosclerotic plaques, plasma, and granulocytes.
- To explore the potential of MMVs as biomarkers in atherosclerosis pathophysiology.
Main Methods:
- Flow cytometry was used to analyze MMV phenotypes (CD14+, CD36+, BLTR1+) in samples from patients with femoral atherosclerosis and healthy controls.
- Gas chromatography was employed to quantify eicosapentaenoic acid and arachidonic acid levels in plasma, granulocytes, and atherosclerotic plaques.
- Statistical analysis was performed to determine correlations between MMV phenotypes and fatty acid levels.
Main Results:
- Patients with atherosclerosis exhibited significantly lower levels of BLTR1+ MVs, CD14+BLTR1+ MVs, and CD14+BLTR1+CD36+ MVs compared to controls.
- In patients, CD14+ MVs and CD14+CD36+ MVs showed an inverse correlation with granulocyte arachidonic acid levels.
- CD14+CD36+ MVs correlated inversely with plasma phospholipid arachidonic acid and positively with triglyceride levels in both patients and controls.
Conclusions:
- This explorative study suggests that BLTR1+ MVs and CD14+CD36+ MVs may serve as indicative markers for atherosclerosis pathophysiology.
- The findings highlight a potential link between specific MMV phenotypes, fatty acid metabolism, and atherosclerotic disease.
- Further research is warranted to validate these MMV phenotypes as reliable biomarkers for atherosclerosis.
Abstract:
Aims: Monocytes/macrophages play a crucial role in the development, progression, and complication of atherosclerosis. In particular, foam cell formation driven by CD36 mediated internalization of oxLDL leads to activation of monocytes and subsequent release of microvesicles (MVs) derived from monocytes (MMVs). Further, pro-inflammatory leukotriene B4 (LTB4) derived from arachidonic acid promotes atherosclerosis through the high-affinity receptor BLTR1. Thus, we aimed to investigate the correlation between different MMV phenotypes (CD14+ MVs) on the one hand, and arachidonic acid and eicosapentaenoic acid contents in different compartments including atherosclerotic plaques, plasma, and granulocytes on the other. Methods and Results: Samples from patients with femoral atherosclerosis and healthy controls were analyzed on an Apogee A60 Micro-PLUS flow cytometer. Platelet-poor plasma was labeled with lactadherin-FITC, anti-CD14-APC, anti-CD36-PE, and anti-BLTR1-AF700. Eicosapentaenoic acid and arachidonic acid content in different compartments in patients were analyzed using gas chromatography. Compared to controls, patients had lower levels of BLTR1+ MVs (p = 0.007), CD14+BLTR1+ MVs (p = 0.007), and CD14+BLTR1+CD36+ MVs (p = 0.001). Further, in patients CD14+ MVs and CD14+CD36+ MVs correlated inversely with arachidonic acid in granulocytes (r = -0.302, p = 0.039 and r = -0.322, p = 0.028, respectively). Moreover, CD14+CD36+ MVs correlated inversely with arachidonic acid in plasma phospholipids in patients (r = -0.315, p = 0.029), and positively with triglyceride in both patients (r = 0.33, p = 0.019) and controls (r = 0.46, p = 0.022). Conclusion: This is the first study of its kind and thus the results are explorative and only indicative. BLTR1+ MVs and CD14+CD36+ MVs has potential as markers of atherosclerosis pathophysiology, but this needs further investigation.
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
Impact of Individuals on Individuals
Impact of Groups on Individuals
Impact of Individuals on a Group
Adler's Individual Psychology
Dosage Regimen: Individualization

